Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 17
- 13F valueReported value at the end of Q2 2026
- $369.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SNGX, Q2 2026
No superinvestor reported holding SNGX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Soligenix, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2025 (view filing) | Oct 2 | 1 day | Schaber Christopher JCHAIRMAN, CEO AND PRESIDENT | PPurchase | +15.1K | $1.32 | +$20.0K | +3,992.6%15.5K after | |
| May 18, 2022 (view filing)6:01 PM ET | May 18 | Same day | Schaber Christopher JCHAIRMAN, CEO AND PRESIDENT | PPurchase | +20.0K | $0.4433 | +$8.87K | +28.5%90.1K after | |
| May 18, 2022 (view filing) | May 18 | Same day | Straube RichardSENIOR VICE PRESIDENT AND CMO | PPurchase | +8.00K | $0.50 | +$4.00K | New position8.00K after | |
| Dec 20, 2021 (view filing) | Dec 17 | 3 days | Schaber Christopher JCHAIRMAN, CEO AND PRESIDENT | PPurchase | +7.00K | $0.74 | +$5.18K | +11.1%70.1K after | |
| Dec 15, 2021 (view filing) | Dec 15 | Same day | Guarino Jonathan L.Senior Vice President and CFO | PPurchase | +1.00K | $0.70 | +$700 | +10.0%11.0K after | |
| Dec 15, 2021 (view filing) | Dec 14 | 1 day | Guarino Jonathan L.Senior Vice President and CFO | PPurchase | +10.0K | $0.71 | +$7.10K | New position10.0K after | |
| Dec 14, 2021 (view filing) | Dec 14 | Same day | Schaber Christopher JChairman, CEO and President | PPurchase | +10.0K | $0.73 | +$7.30K | +18.8%63.1K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Soligenix, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 209,507 | $83.0K | 0.00% | +209,507 | New |
| Jane Street Group, LLC | 207,492 | $82.2K | 0.00% | +207,492 | New |
| XTX Topco Ltd | 157,119 | $62.2K | 0.00% | +136,320+655.4% | Added |
| Geode Capital Management, LLC | 120,267 | $47.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 81,005 | $32.1K | 0.00% | +22,605+38.7% | Added |
| Virtu Financial LLC | 60,903 | $24.0K | 0.00% | +60,903 | New |
| Vanguard Fiduciary Trust Co | 53,914 | $21.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 38,046 | $15.1K | 0.00% | +38,046 | New |
| Morgan Stanley | 3,592 | $1.42K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1,236 | $507 | 0.00% | +1,136+1,136.0% | Added |